No. Those are only included in clinical trials for neoadjuvant treatment or confirmed visible disease in line two treatment after RC.

I am doing fairly well. Nivolumab gives me headaches, fatigue and also occasional diarrhea/abdominal pain and dry skin. But 95% better than DDMVAC.